SCHEMBL3704209

SCHEMBL3704209

Cc1cccc(Cn2cncc2C(CNC(CC(C)C)C(=O)O)C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 4/20 0.44
ACE P12821 3/20 0.44
CYP11B1 P15538 3/20 0.37
CYP11B2 P19099 3/20 0.37
FOLH1 Q04609 1/20 0.36
NTSR1 P30989 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LNPEP Q9UIQ6 1/20 0.36
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7381303 0.90 ACE2 (0.44) ACE2ACECYP11B1CYP11B2FOLH1
SCHEMBL7382791 0.90 ACE2 (0.49) ACE2ACECYP11B1CYP11B2NTSR1
SCHEMBL3710373 0.89 ACE2 (0.43) ACE2ACECYP11B1CYP11B2FOLH1
SCHEMBL3709303 0.89 ACE2 (0.52) ACE2ACECYP11B1CYP11B2KDM4E
SCHEMBL3714339 0.89 ACE2 (0.43) ACE2ACECYP11B1CYP11B2FOLH1
SCHEMBL3715183 0.88 ACE2 (0.47) ACE2ACECYP11B1CYP11B2FOLH1
SCHEMBL3712513 0.87 ACE2 (0.45) ACE2ACECYP11B1CYP11B2FOLH1
SCHEMBL7381318 0.87 TP53 (0.46) ACE2ACEALDH1A1KDM4ECYP3A4
SCHEMBL7384489 0.86 ACE2 (0.43) ACE2ACEALDH1A1KDM4ERECQL
SCHEMBL1655466 0.84 ACE2 (0.48) ACE2ACECYP11B1CYP11B2FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000066104-A9 ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARM INC (US) 2002-08-29 WO claimed
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO claimed
WO-2010093804-A1 ACE2 INHIBITORS FOR REDUCING GASTROINTESTINAL ADVERSE EFFECTS OF CYTOTOXIC AGENTS ORE PHARMACEUTICALS, INC. (US) 2010-08-19 WO disclosed
EP-1183019-A2 ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2002-03-06 EP disclosed
WO-2000066104-A2 ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2000-11-09 WO disclosed